UBS OCONNOR LLC - XENON PHARMACEUTICALS INC ownership

XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 184 filers reported holding XENON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 2.73 and the average weighting 0.4%.

Quarter-by-quarter ownership
UBS OCONNOR LLC ownership history of XENON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,662,772
+11.7%
48,676
+25.9%
0.04%
-10.6%
Q2 2023$1,489,026
-34.4%
38,676
-39.0%
0.05%
-32.9%
Q1 2023$2,268,764
-99.9%
63,391
+16.9%
0.07%
+89.2%
Q3 2022$1,957,000,000
-33.1%
54,208
-43.7%
0.04%
-14.0%
Q2 2022$2,927,000,00096,2080.04%
Other shareholders
XENON PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Ghost Tree Capital, LLC 790,000$12,071,0003.53%
GREAT POINT PARTNERS LLC 700,000$10,696,0002.49%
COMMODORE CAPITAL LP 579,432$8,854,0002.33%
ACUTA CAPITAL PARTNERS, LLC 417,409$6,378,0002.25%
DAFNA Capital Management LLC 406,535$6,212,0001.65%
Tri Locum Partners LP 264,134$4,036,0001.60%
Parkman Healthcare Partners LLC 311,207$4,755,0001.20%
Ghost Tree Capital, LLC 250,000$3,820,0001.12%
Nan Fung Group Holdings Ltd 197,880$3,024,0000.97%
BVF INC/IL 1,571,778$24,017,0000.94%
View complete list of XENON PHARMACEUTICALS INC shareholders